136 related articles for article (PubMed ID: 33217357)
1. Ebola-negative neonates born to Ebola-infected mothers after monoclonal antibody therapy: a case series.
Ottoni MP; Ricciardone JD; Nadimpalli A; Singh S; Katsomya AM; Pokoso LM; Petrucci R
Lancet Child Adolesc Health; 2020 Dec; 4(12):884-888. PubMed ID: 33217357
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S; Dodd LE; Davey RT; Tshiani Mbaya O; Proschan M; Mukadi D; Lusakibanza Manzo M; Nzolo D; Tshomba Oloma A; Ibanda A; Ali R; Coulibaly S; Levine AC; Grais R; Diaz J; Lane HC; Muyembe-Tamfum JJ; ; Sivahera B; Camara M; Kojan R; Walker R; Dighero-Kemp B; Cao H; Mukumbayi P; Mbala-Kingebeni P; Ahuka S; Albert S; Bonnett T; Crozier I; Duvenhage M; Proffitt C; Teitelbaum M; Moench T; Aboulhab J; Barrett K; Cahill K; Cone K; Eckes R; Hensley L; Herpin B; Higgs E; Ledgerwood J; Pierson J; Smolskis M; Sow Y; Tierney J; Sivapalasingam S; Holman W; Gettinger N; Vallée D; Nordwall J;
N Engl J Med; 2019 Dec; 381(24):2293-2303. PubMed ID: 31774950
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.
Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; Diallo MSK; Mukadi-Bamuleka D; Kitenge R; Formenty P; Legand A; Edidi-Atani F; Thaurignac G; Pelloquin R; Mbala-Kingebeni P; Toure A; Ayouba A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S;
Lancet Infect Dis; 2024 Mar; 24(3):266-274. PubMed ID: 38043556
[TBL] [Abstract][Full Text] [Related]
4. One month follow up of a neonate born to a mother who survived Ebola virus disease during pregnancy: a case report in the Democratic Republic of Congo.
Baraka NK; Mumbere M; Ndombe E
BMC Pediatr; 2019 Jun; 19(1):202. PubMed ID: 31215482
[TBL] [Abstract][Full Text] [Related]
5. Live neonates born to mothers with Ebola virus disease: a review of the literature.
Nelson JM; Griese SE; Goodman AB; Peacock G
J Perinatol; 2016 Jun; 36(6):411-4. PubMed ID: 26658125
[TBL] [Abstract][Full Text] [Related]
6. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
7. Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment.
Mbala-Kingebeni P; Aziza A; Di Paola N; Wiley MR; Makiala-Mandanda S; Caviness K; Pratt CB; Ladner JT; Kugelman JR; Prieto K; Chitty JA; Larson PA; Beitzel B; Ayouba A; Vidal N; Karhemere S; Diop M; Diagne MM; Faye M; Faye O; Aruna A; Nsio J; Mulangu F; Mukadi D; Mukadi P; Kombe J; Mulumba A; Villabona-Arenas CJ; Pukuta E; Gonzalez J; Bartlett ML; Sozhamannan S; Gross SM; Schroth GP; Tim R; Zhao JJ; Kuhn JH; Diallo B; Yao M; Fall IS; Ndjoloko B; Mossoko M; Lacroix A; Delaporte E; Sanchez-Lockhart M; Sall AA; Muyembe-Tamfum JJ; Peeters M; Palacios G; Ahuka-Mundeke S
Lancet Infect Dis; 2019 Jun; 19(6):648-657. PubMed ID: 31000464
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program.
Jaspard M; Juchet S; Serra B; Mayoum B; Kanta IM; Camara MS; Mbala P; Kojan R; Malvy D
Int J Infect Dis; 2021 Dec; 113():166-167. PubMed ID: 34587535
[TBL] [Abstract][Full Text] [Related]
9. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.
Caluwaerts S
Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408
[TBL] [Abstract][Full Text] [Related]
10. A premature newborn born to an adolescent girl with acute Ebola virus disease and malaria survives in a resource-limited setting in an Ebola treatment unit in DR Congo: "A case report".
Imani-Musimwa P; Grant E; Feza-Malira M; Mbala-Kingebeni P; Buhoro-Baabo G; Zawadi-Endanda E; Fraterne-Muhayangabo R; Claris-Mwatsi I; Tsongo-Kibendelwa Z; Nyakio-Ngeleza O; Juakali-Kyolov S; Wembonyama-Okitosho S; Sengey-Mushengezi-Amani D; Mukadi-Bamuleka D; Ververs M
Clin Case Rep; 2023 Nov; 11(11):e8253. PubMed ID: 38028078
[TBL] [Abstract][Full Text] [Related]
11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
14. Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges.
Technau KG; Kuhn L; Coovadia A; Carmona S; Sherman G
J Int AIDS Soc; 2017 Apr; 20(1):21436. PubMed ID: 28406596
[TBL] [Abstract][Full Text] [Related]
15. Maternal, fetal, and perinatal outcomes among pregnant women admitted to an Ebola treatment center in the Democratic Republic of Congo, 2018-2020.
Philpott D; Rupani N; Gainey M; Mbong EN; Musimwa PI; Perera SM; Laghari R; Ververs M; Levine AC
PLoS One; 2023; 18(9):e0286843. PubMed ID: 37682812
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study.
Fallah MP; Reilly C; Van Ryn C; Badio M; Camanor SW; Kaler SG; Johnson B; Orone R; Flumo H; Moses SJ; Johnson KL; Gorpudolo N; Gayedyu-Dennis D; Dighero-Kemp B; Fayiah J; Marron L; Hensley LE; Taylor RJ; Higgs ES; Lane HC; Neaton JD; Sneller MC
Lancet Glob Health; 2023 Jul; 11(7):e1053-e1060. PubMed ID: 37349033
[TBL] [Abstract][Full Text] [Related]
17. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics development for Ebola virus disease: A recent scenario.
Chakraborty C
Curr Opin Pharmacol; 2021 Oct; 60():208-215. PubMed ID: 34464933
[TBL] [Abstract][Full Text] [Related]
19. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014.
Baggi FM; Taybi A; Kurth A; Van Herp M; Di Caro A; Wölfel R; Günther S; Decroo T; Declerck H; Jonckheere S
Euro Surveill; 2014 Dec; 19(49):. PubMed ID: 25523968
[TBL] [Abstract][Full Text] [Related]
20. REGN-EB3: First Approval.
Markham A
Drugs; 2021 Jan; 81(1):175-178. PubMed ID: 33432551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
